Jefferies Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,047
Closed -$898K 3195
2019
Q3
$898K Buy
+9,047
New +$898K 0.01% 1574
2019
Q2
Sell
-3,756
Closed -$414K 3011
2019
Q1
$414K Buy
3,756
+1,204
+47% +$126K ﹤0.01% 1676
2018
Q4
$235K Sell
2,552
-4,501
-64% -$455K ﹤0.01% 1756
2018
Q3
$777K Sell
7,053
-2,414
-25% -$251K 0.01% 1452
2018
Q2
$884K Buy
+9,467
New +$815K 0.01% 1335
2017
Q4
Sell
-3,100
Closed -$236K 2925
2017
Q3
$236K Sell
3,100
-5,300
-63% -$401K ﹤0.01% 1993
2017
Q2
$630K Buy
8,400
+895
+12% +$62K ﹤0.01% 1509
2017
Q1
$490K Buy
+7,505
New +$442K ﹤0.01% 1598

Other funds holding PRAH

Jefferies Group's PRAH Position: Q4 2019 in Review

Jefferies Group sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 9,047 shares — an estimated $898K sold.

Jefferies Group first reported a position in PRAH in Q1 2017 and held it in 8 quarters. The position peaked at $898K in Q3 2019. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Jefferies Group reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 9,047 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $898K.
  • Jefferies Group first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 8 quarters.
  • Jefferies Group's PRA Health Sciences, Inc. position peaked at $898K in Q3 2019.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.